Herbert Bonkovsky
Affiliations: | University of Connecticut, Storrs, CT, United States |
Area:
Molecular Biology, GeneticsGoogle:
"Herbert Bonkovsky"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bonkovsky HL, Rudnick SP, Ma CD, et al. (2023) Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive Diseases and Sciences |
| Ventura P, Bonkovsky HL, Gouya L, et al. (2021) Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study. Liver International : Official Journal of the International Association For the Study of the Liver |
| Rudnick S, Bonkovsky HL. (2020) Editorial: hepatitis C and porphyria cutanea tarda in 2020. Alimentary Pharmacology & Therapeutics. 51: 1432-1434 |
| Thapar M, Rudnick S, Bonkovsky HL. (2020) Givosiran, a novel treatment for acute hepatic porphyrias Expert Review of Precision Medicine and Drug Development. 6: 9-18 |
| Sendi H, Mehrab-Mohseni M, Russo MW, et al. (2019) Baseline Hepatic Levels of miR-29b and Claudin are Respectively Associated with the Stage of Fibrosis and HCV RNA in Hepatitis C. Clinical & Experimental Gastroenterology & Hepatology. 1 |
| O'Brien TR, Pfeiffer RM, Paquin A, et al. (2015) Comparison of Functional Variants in IFNL4 and IFNL3 for Association with Hepatitis C Virus Clearance. Journal of Hepatology |
| Sendi H, Mehrab-Mohseni M, Foureau DM, et al. (2015) MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 1315-23 |
| Hou W, Bonkovsky HL. (2013) Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. World Journal of Gastroenterology : Wjg. 19: 7836-45 |
| Russo MW, Narang T, Eskind L, et al. (2013) Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection. Digestive Diseases and Sciences. 58: 3010-6 |
| Ghosh S, Kaplan KJ, Schrum LW, et al. (2013) Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease. International Review of Cell and Molecular Biology. 302: 279-319 |